Tensi+ for Treating Overactive Bladder

Part of paid clinical trials in Beverly Hills, California.

Sponsor
Stimuli Technology
Study ID
NCT07300904
Status
Recruiting
Apply to this trial

Conditions

  • Overactive Bladder (OAB)

Eligibility Criteria

Sex
ALL
Age
22 Years - N/A
Healthy Volunteers
Not accepted

Interventions

  • Tensi+ — DEVICE
    Transcutaneous Tibial Nerve Stimulation

Study Details

The purpose of the study is to evaluate the safety and effectiveness of the Tensi+ device using Transcutaneous Posterior Tibial Nerve Stimulation (TPTNS) for treating patients suffering from OAB symptoms urinary frequency, urgency, with or without urge urinary incontinence.

Key Dates

First listed
Dec 24, 2025
Start date
May 26, 2026
Status verified
Sep 2026
Primary completion
Jan 31, 2027
Completion
Jan 31, 2027

Study Design

Enrollment
60 participants (estimated)
Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT

Arms

  • Active Comparator: Tensi+ device to be delivered for use by patient
  • Sham Comparator: Identical Tensi+ Sham device to be delivered for use by patient

Primary Outcome Measure

Treatment success [ Time Frame: 12 weeks ]

Central Contacts

Locations (2)

FacilityCityStateZIPSite coordinators
Cedars-SinaiBeverly HillsCalifornia90211
Karyn Eilber
[email protected]
310-385-2992
Karyn Eilber (PRINCIPAL_INVESTIGATOR)
NYU Langone HealthNew YorkNew York10017
Benjamin Brucker
[email protected]
646-825-6324
Benjamin Brucker (PRINCIPAL_INVESTIGATOR)

Find similar trials in Beverly Hills, CA

By research site
Cedars-Sinai· Beverly Hills, CANYU Langone Health· New York, NY

Related Studies